Inhaler have announced details of UK and European headline dates in early 2020, including a show at London’s Heaven on February 20
th.
The Dublin quartet recently completed a UK and European tour that saw them sell over 7,000 tickets and play to frenzied, sold-out crowds. They are currently in the US supporting Blossoms, before heading to Mexico, and have announced a new run of dates in the UK for next year that will include a show at London’s Heaven on Thursday 20th February, their biggest headline show to date. Kasabian recently announced Inhaler as one of the support acts at their huge hometown show at Leicester’s Victoria Park next summer.
Four friends who formed the band in school, Elijah Hewson, Robert Keating, Ryan McMahon and Josh Jenkinson bonded over a love of similar groups, taking in The Stone Roses, Joy Division, The Strokes, Depeche Mode, Interpol, Kings Of Leon, The Cure and more.
Over a handful of singles, they have amassed a diehard fanbase, with their tracks being streamed over 7 million times. They make songs about being young and finding your way, music that connects. “I’m just trying to write about the joy of being alive, being a teenager, and the bad things that can come with that. I don’t like it to be all happy, I don’t like it to be all sad,” says frontman Hewson.
Inhaler tour dates are as follows:
DECEMBER 2019
9 – Manchester Gorilla (SOLD OUT)
10 – London Garage (SOLD OUT)
18 – Dublin Button Factory (SOLD OUT)
19 – Dublin Button Factory (SOLD OUT)
JANUARY 2020
16 – Amsterdam Melkweg
FEBRUARY 2020
12 – Liverpool O2 Academy
13 – Birmingham O2 Academy2
14 – Nottingham Rescue Rooms
15 – Manchester Academy 2
17 – Brighton Concorde 2
18 – Cardiff Tramshed
20 – London Heaven
21 – Leeds Beckett Students’ Union
22 – Newcastle Riverside
23 – Glasgow SWG3 Warehouse
28 – Madrid Sala Shoko
29 – Barcelona Sala Razz
MARCH 2020
2 – Paris La Maroquinerie
3 – Antwerp Trix
5 – Berlin Columbia Theater
6 – Hamburg Gruenspan
Much admired Coventry-based 5 piece guitar band FEET are special guests on all UK dates.